Welcome to our dedicated page for Edible Garden SEC filings (Ticker: EDBL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Edible Garden AG Incorporated filings document material events, securities actions and operating updates for a Nasdaq-listed controlled environment agriculture company with publicly traded common stock and warrants. The company’s disclosures cover fresh produce and consumer packaged goods operations, financial results, retail distribution, production infrastructure and related business updates.
Recent 8-K filings describe unregistered equity issuances tied to Series B preferred stock exchanges, secured debt financing, material definitive agreements for processing and packaging equipment, and amendments affecting the company’s common stock, including a reverse stock split. The filing record also documents capital structure, warrant adjustments, governance actions and risk-related terms in financing agreements.
Edible Garden AG Incorporated entered into exchange agreements with Streeterville Capital to convert preferred stock into common shares. The company exchanged 1,222 shares of Series B Preferred Stock, with an aggregate stated value of $1,222,000, for 3,253,455 shares of common stock. The exchange shares were issued based on the Nasdaq Minimum Price of the common stock on the day before the agreements were signed and were issued as unregistered securities under the Section 3(a)(9) exemption of the Securities Act.
Edible Garden AG has called a virtual annual stockholder meeting for June 17, 2026, with May 6, 2026 as the record date and 5,469,314 common shares entitled to vote. Stockholders will elect five directors, ratify CBIZ as auditor for 2026, and consider an adjournment proposal.
The most significant item asks investors to authorize the board, any time within one year, to amend the charter to conduct one or more reverse stock splits of the common stock in a range from 1‑for‑5 up to an aggregate 1‑for‑250 ratio, primarily to help maintain Nasdaq listing if the share price weakens.
The proxy details governance structures, committee independence, and executive pay. CEO James Kras received 2025 total compensation of $2,919,365, including salary, a $500,000 transaction bonus, and equity awards each valued at $1,000,000 under the 2025 equity plan. The company also discloses related‑party dealings with Streeterville Capital, which holds all 11,103 outstanding Series B preferred shares and significant voting power limits tied to 9.99% of common stock.
Edible Garden AG Incorporated reported first-quarter 2026 revenue of $3.3 million, up from $2.7 million a year earlier, driven mainly by strong growth in cut herb sales across its retail customer base.
Operating expenses rose sharply to $10.0 million from $5.6 million, largely due to higher cost of goods sold and about $2.7 million of depreciation and amortization, including accelerated depreciation tied to the company’s pivot toward ready-to-drink clean nutrition manufacturing at its Prairie Hills facility. The company recorded an income tax benefit of $3.4 million from selling New Jersey net operating losses, reducing its net loss to $3.7 million versus $3.3 million in the prior-year quarter.
Cash was $2.0 million as of March 31, 2026, with total assets of $17.5 million and total debt of $2.7 million. Management continues to warn of substantial doubt about its ability to continue as a going concern and expects to require additional financing to fund operations beyond the near term.
Edible Garden AG reported strong top-line growth but wider operating losses for the three months ended March 31, 2026. Revenue rose 22.9% to about $3.3 million from $2.7 million, driven by roughly 46% growth in cut herb sales and expansion across vitamins, supplements, condiments, and international markets.
Total operating expenses increased to about $10.0 million from $5.6 million, mainly from higher cost of goods sold due to a sales mix shift toward third‑party sourced cut herbs and a sharp rise in depreciation tied to the company’s pivot into ready‑to‑drink (RTD) clean nutrition manufacturing. The company recorded an income tax benefit of roughly $3.4 million from selling New Jersey state tax benefits, which helped limit the net loss to about $3.7 million, compared with a $3.3 million loss a year earlier.
Management highlighted continued retail expansion to more than 6,000 locations and progress integrating Tetra Pak processing for shelf‑stable RTD products, positioning the business as a broader clean‑label nutrition platform despite current losses.
Edible Garden AG Incorporated is soliciting proxies for its virtual Annual Meeting on June 17, 2026. The Board set the record date as May 6, 2026 and recommends votes for director nominees, ratification of CBIZ as auditor, and approval of a charter amendment to permit the Board, in its discretion, to effect one or more reverse stock splits at ratios ranging from 1-for-5 to 1-for-250. The proposal would give the Board authority to implement or abandon any reverse split prior to the one-year anniversary of the meeting. As of the record date, the Company reports 5,469,314 shares of common stock outstanding.
The proxy also seeks approval to adjourn the meeting if needed and asks stockholders to ratify audit firm appointment and elect five directors. The Board discloses related-party arrangements with Streeterville Capital, LLC (holder of Series B Preferred Stock) and summarizes executive compensation, employment agreements, and the 2025 equity plan.
Edible Garden AG Incorporated filed Amendment No. 1 to its 2025 annual report to add Part III information on directors, executive compensation, ownership, related-party transactions, and auditor fees. The amendment does not change or update the financial statements in the original filing.
The company reports aggregate market value of non‑affiliate equity of about $7.7 million as of June 30, 2025 and 5,213,691 common shares outstanding as of April 27, 2026. CEO James Kras received $2,919,365 in 2025 compensation, driven by salary, a $500,000 transaction bonus and $2.0 million in equity awards under a new employment agreement with significant severance and change‑in‑control protections.
The filing outlines a 2025 officer and director equity plan with up to 777,862 shares available, director stock awards, and detailed board committee structures. It also highlights extensive related‑party financing with Streeterville Capital and affiliates, including $3.5 million of Series B Preferred Stock issuance, promissory notes, and a favorable Iowa facility lease, as well as 2025 audit and other fees of $451.9 thousand.
Edible Garden AG Incorporated reported an unregistered exchange of preferred stock into common shares. On April 21, 2026, the company entered into exchange agreements with Streeterville Capital, LLC to swap 3,301 shares of Series B Preferred Stock for 3,587,478 shares of common stock.
The Series B Preferred Stock had an aggregate stated value of $3,301,000, or $1,000 per share. The number of common shares issued was calculated by dividing this stated value by the Nasdaq Minimum Price of the company’s common stock on the trading day immediately before the agreements. The exchange was conducted under the Section 3(a)(9) exemption and the shares were not registered under the Securities Act of 1933.
Edible Garden AG Incorporated outlines a year of strategic expansion alongside significant financial strain. The controlled environment agriculture company reported net losses of approximately $17.3 million in 2025 and $11.1 million in 2024, and its auditors expressed substantial doubt about its ability to continue as a going concern.
The business is evolving beyond fresh herbs into higher-margin, shelf-stable nutrition and ready-to-drink beverages. A 200,000-square-foot Iowa facility is being transformed into an aseptic RTD manufacturing hub under interim agreements with Tetra Pak, with first-phase production anticipated in 2027, subject to a final supply agreement, capital, and approvals.
Growth initiatives also include acquiring a five-acre Michigan greenhouse and $12.0 million of aquaculture assets with patented water-treatment technology, expanding its Zero-Waste Inspired platform. However, the company remains dependent on external financing, faces intense competition, weather and cost pressures, and relies heavily on a small group of grocery customers that accounted for 88.2% of 2025 revenue.
Edible Garden reported 2025 results showing weaker profitability while accelerating a shift into higher-margin, shelf-stable and ready-to-drink (RTD) nutrition products. Full-year revenue was approximately $12.8 million, down from $13.9 million in 2024, as the company exited lower-margin produce lines.
Full-year gross profit declined to about $(0.2) million from $2.3 million, with gross margin falling to (1.6)% from 16.7%, largely due to elevated fourth-quarter procurement and logistics costs. Selling, general and administrative expenses rose to roughly $15.6 million from $11.6 million, reflecting investments in personnel, infrastructure, and acquisitions.
Operationally, cut herbs unit sales grew about 22.9% year-over-year and vitamin and supplement unit sales rose roughly 47.7%, including approximately 78.6% growth in international vitamin and supplement revenue. The company expanded to nearly 6,000 store locations and is developing an RTD manufacturing hub in the Midwest, supported by planned Tetra Pak processing integration.